NovImmune SA
Biotechnology · Plan-les-Ouates, Geneva
NovImmune SA is a Swiss biotechnology company based in Plan-les-Ouates, Canton of Geneva (UID CHE-104.261.899).
Board members & signatories
- Hunziker Erich — Mitglied des Verwaltungsrates
- Blum Holger — Mitglied des Verwaltungsrates
Registered purpose
développer commercialement des produits résultant de la recherche bio-médicale de haut niveau, principalement, mais pas exclusivement , dans le domaine de l'immunologie, des maladies autoimmunes et du contrôle de l'expression des gènes.…
Source: Swiss commercial register (Zefix / SOGC) and Alpintel analysis · Data as of March 2026
What NovImmune does
OFFERING
NovImmune SA focuses on the development of native bispecific therapeutics, particularly targeting CD47 and CD28 pathways. Their technology involves the creation of multispecific yet natural κλ bodies, which are designed to enhance therapeutic efficacy in treating tumors.
Unlock the full analysis →Similar companies
- Immunovant Sciences GmbH — Biotechnology · Basel
- Engimmune Therapeutics AG — Biotechnology · Allschwil
- ImmunOs Therapeutics AG — Pharmaceuticals · Schlieren
- Neurimmune AG — Biotechnology · Schlieren
- AC Immune AG — Biotechnology · Lausanne
- Neurimmune Holding AG — Biotechnology · Schlieren
Find every biotechnology company in Switzerland
Alpintel searches all 710,000 Swiss companies with AI — filter by industry, size, revenue, region and ownership in seconds.
family-owned biotechnology companies with 50+ employees…Search →Full profiles from CHF 49/month · Cancel anytime